Related references
Note: Only part of the references are listed.Identification of bacteria-derived HLA-bound peptides in melanoma
Shelly Kalaora et al.
NATURE (2021)
Bacillus Calmette-Guerin Overexpressing an Endogenous Stimulator of Interferon Genes Agonist Provides Enhanced Protection Against Pulmonary Tuberculosis
Ruchi Jain Dey et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Metabolomics of lung cancer: Analytical platforms and their applications
Hamada A. A. Noreldeen et al.
JOURNAL OF SEPARATION SCIENCE (2020)
C/EBPβ-Dependent Epigenetic Memory Induces Trained Immunity in Hematopoietic Stem Cells
Berengere de Laval et al.
CELL STEM CELL (2020)
BCG Vaccination in Humans Elicits Trained Immunity via the Hematopoietic Progenitor Compartment
Branko Cirovic et al.
CELL HOST & MICROBE (2020)
Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly
Evangelos J. Giamarellos-Bourboulis et al.
CELL (2020)
Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling
Anthony C. Antonelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Trained Innate Immunity, Epigenetics, and Covid-19
Alberto Mantovani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Recombinant BCG overexpressing STING agonist elicits trained immunity and improved antitumor efficacy in non-muscle invasive bladder cancer
A. K. Singh et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Immunodietica: interrogating the role of diet in autoimmune disease
Iosif M. Gershteyn et al.
INTERNATIONAL IMMUNOLOGY (2020)
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage
Aurelie Fluckiger et al.
SCIENCE (2020)
Defining trained immunity and its role in health and disease
Mihai G. Netea et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial
Niannian Ji et al.
ONCOIMMUNOLOGY (2019)
Prediction of BCG responses in non-muscle-invasive bladder cancer in the era of novel immunotherapeutics
Aleksander Slusarczyk et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2019)
Immune Checkpoint Inhibitors: Basics and Challenges
Bin Li et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Immune adjuvant therapy using Bacillus Calmette-Guerin cell wall skeleton (BCG-CWS) in advanced malignancies A phase 1 study of safety and immunogenicity assessments
Sumiyuki Nishida et al.
MEDICINE (2019)
Cooking shapes the structure and function of the gut microbiome
Rachel N. Carmody et al.
NATURE MICROBIOLOGY (2019)
Mycobacterium bovis BCG in metastatic melanoma therapy
Martha Lucia Ruiz Benitez et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2019)
Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy
Cristina Gil-Cruz et al.
SCIENCE (2019)
Immunostimulatory gut bacteria
Laurence Zitvogel et al.
SCIENCE (2019)
Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma
Ines Pires da Silva et al.
CLINICAL CANCER RESEARCH (2019)
Advanced stage melanoma therapies: Detailing the present and exploring the future
Chelsea Luther et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
STING signaling and host defense against microbial infection
Jeonghyun Ahn et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development
Ellen V. Rothenberg et al.
FRONTIERS IN IMMUNOLOGY (2019)
From neural crest cells to melanocytes: cellular plasticity during development and beyond
Niels Vandamme et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity
Ioannis Mitroulis et al.
CELL (2018)
BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis
Eva Kaufmann et al.
CELL (2018)
BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity
Rob J. W. Arts et al.
CELL HOST & MICROBE (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
The role of neoantigen in immune checkpoint blockade therapy
Ming Yi et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2018)
Modes of invasion during tumour dissemination
Pahini Pandya et al.
MOLECULAR ONCOLOGY (2017)
Progress and prospects of early detection in lung cancer
Sean Blandin Knight et al.
OPEN BIOLOGY (2017)
Mycobacterium bovis Bacillus calmette-guerin alters Melanoma Microenvironment Favoring antitumor T cell responses and improving M2 Macrophage Function
Ricardo D. Lardone et al.
FRONTIERS IN IMMUNOLOGY (2017)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2017)
Early vaccination protects against childhood leukemia: A systematic review and meta-analysis
Mostafa Ebraheem Morra et al.
SCIENTIFIC REPORTS (2017)
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases
Mark B. Faries et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Transdermal Gene Delivery by Functional Peptide-Conjugated Cationic Gold Nanoparticle Reverses the Progression and Metastasis of Cutaneous Melanoma
Jie Niu et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Epigenetic Memory Underlies Cell-Autonomous Heterogeneous Behavior of Hematopoietic Stem Cells (vol 167, pg 1310, 2016)
Vionnie W. C. Yu et al.
CELL (2017)
Host and Environmental Factors Influencing Individual Human Cytokine Responses
Rob ter Horst et al.
CELL (2016)
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
Sam S. Chang et al.
JOURNAL OF UROLOGY (2016)
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial
F. Stephen Hodi et al.
LANCET ONCOLOGY (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Assessment of Relationship between Wilms' Tumor Gene (WT1) Expression in Peripheral Blood of Acute Leukemia Patients and Serum IL-12 and C3 Levels
Omran Rezai et al.
Asian Pacific Journal of Cancer Prevention (2015)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Bone-Marrow-Resident NK Cells Prime Monocytes for Regulatory Function during Infection
Michael H. Askenase et al.
IMMUNITY (2015)
Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus
Chelsea E. Stamm et al.
IMMUNOLOGICAL REVIEWS (2015)
A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis
Bappaditya Dey et al.
NATURE MEDICINE (2015)
Inflammation and cancer: advances and new agents
Shanthini M. Crusz et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
Interaction of Pattern Recognition Receptors with Mycobacterium Tuberculosis
Esmaeil Mortaz et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2015)
Fifteen-minute consultation: Bacillus Calmette-Guerin abscess and lymphadenitis
Andrew Riordan et al.
ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION (2014)
Roles of tumor suppressors in regulating tumor-associated inflammation
L. Yang et al.
CELL DEATH AND DIFFERENTIATION (2014)
BCG-induced trained immunity in NK cells: Role for non-specific protection to infection
Johanneke Kleinnijenhuis et al.
CLINICAL IMMUNOLOGY (2014)
Innate immune memory: towards a better understanding of host defense mechanisms
Jessica Quintin et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
The mechanism of action of BCG therapy for bladder cancer-a current perspective
Gil Redelman-Sidi et al.
NATURE REVIEWS UROLOGY (2014)
Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer
Kathrin Buffen et al.
PLOS PATHOGENS (2014)
Infection and Cancer: Global Distribution and Burden of Diseases
Jin-Kyoung Oh et al.
ANNALS OF GLOBAL HEALTH (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
Epidemiological and histopathological profile of cutaneous melanoma at a center in northeastern Brazil from 2000 to 2010
Camila Maria Arruda Vilanova et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2013)
Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma
Einar Birkeland et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
Thomas F. Gajewski et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
STING and the innate immune response to nucleic acids in the cytosol
Dara L. Burdette et al.
NATURE IMMUNOLOGY (2013)
BCG immunotherapy for bladder cancer-the effects of substrain differences
Christine Gan et al.
NATURE REVIEWS UROLOGY (2013)
Combined Intralesional Bacille Calmette-Guerin (BCG) and Topical Imiquimod for In-transit Melanoma
Travis B. Kidner et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials
Christine M. Lovly et al.
PLOS ONE (2012)
Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
Johanneke Kleinnijenhuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer
Claire Biot et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Blocking IL-10 enhances bacillus Calmette-Guerin induced T helper Type 1 immune responses and anti-bladder cancer immunity
Yi Luo
ONCOIMMUNOLOGY (2012)
Role of bacillus Calmette-Guerin in the treatment of advanced melanoma
John H. Stewart et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Mark S. Diamond et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
RAF protein-serine/threonine kinases: Structure and regulation
Robert Roskoski
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
BRAF, a Target in Melanoma Implications for Solid Tumor Drug Development
Keith T. Flaherty et al.
CANCER (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after Bacillus Calmette-Guérin (BCG) immunotherapy
A. M. JACKSON et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Adaptive immune features of natural killer cells
Joseph C. Sun et al.
NATURE (2009)
Risk of lymphoma and leukaemia after bacille Calmette-Guerin and smallpox vaccination: A Danish case-cohort study
Marie Villumsen et al.
VACCINE (2009)
Intravesical Therapy for Urothelial Carcinoma of the Urinary Bladder: A Critical Review
Daher C. Chade et al.
INTERNATIONAL BRAZ J UROL (2009)
Computational Modeling of the Hematopoietic Erythroid-Myeloid Switch Reveals Insights into Cooperativity, Priming, and Irreversibility
Vijay Chickarmane et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Inflammation: Gearing the journey to cancer
Joydeb Kumar Kundu et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Hiroki Ishikawa et al.
NATURE (2008)
UFT (tegafur and uracil) as postoperative adjuvant chemotherapy for solid tumors (Carcinoma of the lung, stomach, colon/rectum, and breast): Clinical evidence, mechanism of action, and future direction
Fumihiro Tanaka
SURGERY TODAY (2007)
Bifurcation dynamics in lineage-commitment in bipotent progenitor cells
Sui Huang et al.
DEVELOPMENTAL BIOLOGY (2007)
DAMPs, PAMPs and alarmins: all we need to know about danger
Marco E. Bianchi
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and bacillus Calmette-Guerin cell wall skeleton stimulation
Masaru Udagawa et al.
CLINICAL CANCER RESEARCH (2006)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Infection, immune responses and the aetiology of childhood leukaemia
M Greaves
NATURE REVIEWS CANCER (2006)
The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine
N Craft et al.
JOURNAL OF IMMUNOLOGY (2005)
Low dose BCG as adjuvant therapy for superficial bladder cancer and literature review
CW Cheng et al.
ANZ JOURNAL OF SURGERY (2004)
Simultaneous blocking of human toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guerin peptidoglycan
J Uehori et al.
INFECTION AND IMMUNITY (2003)
Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine
EC Hsueh et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates
JC Walsh et al.
IMMUNITY (2002)
Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer
SS Hecht
CARCINOGENESIS (2002)
BCG and autoimmunity: Another two-edged sword
Y Shoenfeld et al.
JOURNAL OF AUTOIMMUNITY (2001)
Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin:: Involvement of Toll-like receptors
S Tsuji et al.
INFECTION AND IMMUNITY (2000)
Share Paper
